OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL

Authors :: Daniel E. Singer
Guenter Breithardt
Scott D. Berkowitz
Derek Cyr
Somasekhara R. Balla
Robert M. Califf
Manesh R. Patel
Richard Becker
Yuliya Lokhnygina
Werner Hacke
Jonathan P. Piccini
Keith A. A. Fox
Christopher C. Nessel
Kenneth W. Mahaffey
Graeme J. Hankey
Jonathan L. Halperin
Source :: ResearcherID
Publisher :: American College of Cardiology Foundation. Published by Elsevier Inc.
Abstract: Obesity is a risk factor for development of atrial fibrillation (AF). The impact on stroke outcomes in patients with AF is unknown. We investigated stroke outcomes in normal weight ([NW] BMI 18.50-24.99 kg/m2), overweight ([OW] BMI 25.00-29.99kg/m2), and obese ([OB] BMI ≥30 kg/m2) patients with AF

Full Text Access

Tools